Antistaphylococcal Nanocomposite Films Based on Enzyme−Nanotube Conjugates

Ravindra C. Pangule(Rensselaer Polytechnic Institute), Sarah J. Brooks(Rensselaer Polytechnic Institute), Cerasela Zoica Dinu(Rensselaer Polytechnic Institute), Shyam Sundhar Bale(Rensselaer Polytechnic Institute), Sharon L. Salmon(Albany Medical Center Hospital), Guangyu Zhu(Rensselaer Polytechnic Institute), Dennis W. Metzger(Albany Medical Center Hospital), Ravi S. Kane(Rensselaer Polytechnic Institute), Jonathan S. Dordick(Rensselaer Polytechnic Institute)
ACS Nano
July 6, 2010
Cited by 119

Abstract

Infection with antibiotic-resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) is one of the primary causes of hospitalizations and deaths. To address this issue, we have designed antimicrobial coatings incorporating carbon nanotube-enzyme conjugates that are highly effective against antibiotic-resistant pathogens. Specifically, we incorporated conjugates of carbon nanotubes with lysostaphin, a cell wall degrading enzyme, into films to impart bactericidal properties against Staphylococcus aureus and Staphylococcus epidermidis. We fabricated and characterized nanocomposites containing different conjugate formulations and enzyme loadings. These enzyme-based composites were highly efficient in killing MRSA (>99% within 2 h) without release of the enzyme into solution. Additionally, these films were reusable and stable under dry storage conditions for a month. Such enzyme-based film formulations may be used to prevent growth of pathogenic and antibiotic-resistant microorganisms on various common surfaces in hospital settings. Polymer and paint films containing such antimicrobial conjugates, in particular, could be advantageous to prevent risk of staphylococcal-specific infection and biofouling.


Related Papers

No related papers found

Powered by citation graph analysis